BRPI1010693A2 - métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito - Google Patents

métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito

Info

Publication number
BRPI1010693A2
BRPI1010693A2 BRPI1010693A BRPI1010693A BRPI1010693A2 BR PI1010693 A2 BRPI1010693 A2 BR PI1010693A2 BR PI1010693 A BRPI1010693 A BR PI1010693A BR PI1010693 A BRPI1010693 A BR PI1010693A BR PI1010693 A2 BRPI1010693 A2 BR PI1010693A2
Authority
BR
Brazil
Prior art keywords
subject
computer
scoring
kits
methods
Prior art date
Application number
BRPI1010693A
Other languages
English (en)
Inventor
A Wingrove James
R Elashoff Michael
Beineke Philip
Rosenberg Steven
E Daniels Susan
G Tingley Whittemore
Original Assignee
Cardiodx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiodx Inc filed Critical Cardiodx Inc
Publication of BRPI1010693A2 publication Critical patent/BRPI1010693A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Analytical Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Primary Health Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)

Abstract

métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito são proporcionados marcadores e métodos úteis para avaliar doença da artéria coronária em um sujeito, juntamente com kits para medir a sua expressão. são também proporcionados modelos preditivos, com base nos marcadores, assim como também modalidades de sistemas de computador e de software dos modelos para pontuação e opcionalmente classificação de amostras.
BRPI1010693A 2009-06-15 2010-06-15 métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito BRPI1010693A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18720309P 2009-06-15 2009-06-15
US24519009P 2009-09-23 2009-09-23
PCT/US2010/038712 WO2010148017A1 (en) 2009-06-15 2010-06-15 Determination of coronary artery disease risk.

Publications (1)

Publication Number Publication Date
BRPI1010693A2 true BRPI1010693A2 (pt) 2019-07-16

Family

ID=43356727

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010693A BRPI1010693A2 (pt) 2009-06-15 2010-06-15 métodos implementados por computador para marcar e/ou pontuar uma primeira amostra obtida a partir de um sujeito, meios de armazenamento legível em computador de armazenamento de código de programa executável e métodos, sistema e kits de predição de cad em um sujeito

Country Status (13)

Country Link
US (3) US9122777B2 (pt)
EP (1) EP2443449B1 (pt)
JP (1) JP2012529914A (pt)
KR (1) KR20120046171A (pt)
CN (1) CN102803951A (pt)
AU (1) AU2010260152A1 (pt)
BR (1) BRPI1010693A2 (pt)
CA (1) CA2765145A1 (pt)
DK (1) DK2443449T3 (pt)
EA (1) EA201270020A1 (pt)
IL (1) IL216875A0 (pt)
SG (2) SG10201403152QA (pt)
WO (1) WO2010148017A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9122777B2 (en) 2009-06-15 2015-09-01 Cardiodx, Inc. Method for determining coronary artery disease risk
MX2012014268A (es) 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
EP2603622A4 (en) 2010-08-13 2015-04-22 Somalogic Inc BIOMARKERS FOR PANCREATIC CANCER AND USES THEREOF
WO2012094366A1 (en) * 2011-01-06 2012-07-12 Cardiodx, Inc. Circulating mirnas as biomarkers for coronary artery disease
SG10201607331WA (en) * 2011-09-30 2016-11-29 Somalogic Inc Cardiovascular risk event prediction and uses thereof
CN104101715A (zh) * 2014-07-15 2014-10-15 重庆医科大学附属儿童医院 检测dock8蛋白的试剂盒及非诊断目的检测dock8蛋白的方法
WO2016076899A1 (en) * 2014-11-14 2016-05-19 Medidata Solutions, Inc. System and method for determining subject conditions in mobile health clinical trials
AU2016303472B2 (en) 2015-07-31 2020-08-27 Immunewalk Therapeutics, Inc. Motile sperm domain containing protein 2 and inflammation
EP3328401B1 (en) 2015-07-31 2020-10-14 Vascular Biogenics Ltd. Motile sperm domain containing protein 2 and cancer
US20180356432A1 (en) * 2015-09-01 2018-12-13 Cardiodx, Inc. Markers for coronary artery disease and uses thereof
US11056218B2 (en) 2016-05-31 2021-07-06 International Business Machines Corporation Identifying personalized time-varying predictive patterns of risk factors
CN106327476A (zh) * 2016-08-25 2017-01-11 于洋 一种ct图像处理方法及装置
CN110225982A (zh) 2016-09-01 2019-09-10 乔治·华盛顿大学 冠状动脉疾病的血液rna生物标记
US10832815B2 (en) 2017-05-18 2020-11-10 International Business Machines Corporation Medical side effects tracking
CN107238712B (zh) * 2017-06-05 2018-12-28 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死预后中的应用
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
CN107292128A (zh) * 2017-06-27 2017-10-24 湖南农业大学 一种配对互作基因检测方法及预测模型
CN107937521B (zh) * 2017-11-19 2019-01-04 武汉迈特维尔生物科技有限公司 用于检测肾上腺皮质癌的试剂盒
US20210217485A1 (en) * 2018-01-15 2021-07-15 Chang Gung Memorial Hospital, Linkou Method of establishing a coronary artery disease prediction model for screening coronary artery disease
CN111354464B (zh) * 2018-12-24 2024-05-17 深圳先进技术研究院 Cad预测模型建立方法、装置以及电子设备
CN111789949A (zh) * 2019-04-08 2020-10-20 北京昱嘉科技集团有限公司 基于特异性趋化因子受体的阿尔兹海默病治疗靶点
US11564738B2 (en) * 2019-05-06 2023-01-31 Biosense Webster (Israel) Ltd. Using pulmonary vein isolation for patients with atrial fibrillation
RU2740246C1 (ru) * 2020-03-20 2021-01-12 Жанна Залкуфовна Отарова Способ определения высокого риска атеросклероза сонных артерий при ревматоидном артрите
TW202201007A (zh) * 2020-05-19 2022-01-01 美商獵鷹生科有限責任公司 以灌注不足為特徵的病症的檢測和治療
JP2023547026A (ja) 2020-09-10 2023-11-09 バスキュラー バイオジェニックス リミテッド 運動精子ドメイン含有タンパク質２抗体およびその使用法
CN112835316B (zh) * 2021-01-06 2022-04-19 重庆医科大学 新生儿败血症休克预测系统及监控设备
CN113295874B (zh) * 2021-05-25 2022-03-04 广东源心再生医学有限公司 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品
CN113667740B (zh) * 2021-08-27 2023-12-26 河北医科大学第二医院 分子标志物组合在诊断心血管疾病中的应用
CN113667739B (zh) * 2021-08-27 2023-12-26 河北医科大学第二医院 冠状动脉疾病的诊断标志物组合
CN120121843B (zh) * 2025-02-24 2026-02-10 梅州市人民医院(梅州市医学科学院) Ifitm家族蛋白在诊断冠状动脉粥样硬化的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151479A1 (en) * 2000-01-31 2002-10-17 Rosen Craig A. Nucleic acids, proteins, and antibodies
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20030099958A1 (en) * 2001-09-05 2003-05-29 Vitivity, Inc. Diagnosis and treatment of vascular disease
US20050032066A1 (en) 2003-08-04 2005-02-10 Heng Chew Kiat Method for assessing risk of diseases with multiple contributing factors
US20070238124A1 (en) 2003-10-16 2007-10-11 Chibout Salah D Differentially expressed genes related to coronary artery disease
US20070218513A1 (en) 2003-10-16 2007-09-20 Novartis Ag Differentially Expressed Genes Related to Coronary Artery Disease
WO2005103720A1 (en) 2004-03-29 2005-11-03 Medstar Research Institute, Inc. Methods of diagnosing cardiovascular disease
US20070105133A1 (en) * 2005-06-13 2007-05-10 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20070015170A1 (en) * 2005-07-12 2007-01-18 Oy Jurilab Ltd Method and kit for detecting a risk of coronary heart disease
US20100035963A1 (en) 2005-09-09 2010-02-11 Ayelet Chajut Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease
CA2659082A1 (en) * 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008080126A2 (en) * 2006-12-22 2008-07-03 Aviir, Inc. Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease
KR101571523B1 (ko) * 2007-02-21 2015-11-24 디코드 제네틱스 이에이치에프 심혈관 질환과 연관된 유전적 감수성 변이
US7695916B2 (en) 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
DK2155907T3 (da) * 2007-04-30 2015-08-31 Decode Genetics Ehf Genetiske varianter nyttige til risikovurdering af koronararteriesygdom og myokardieinfarkt
US20110184712A1 (en) 2007-10-11 2011-07-28 Cardiodx, Inc. Predictive models and methods for diagnosing and assessing coronary artery disease
WO2010038104A1 (en) * 2008-10-03 2010-04-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination of cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event.
US9122777B2 (en) 2009-06-15 2015-09-01 Cardiodx, Inc. Method for determining coronary artery disease risk

Also Published As

Publication number Publication date
WO2010148017A1 (en) 2010-12-23
CA2765145A1 (en) 2010-12-23
US20150315652A1 (en) 2015-11-05
SG176692A1 (en) 2012-01-30
SG10201403152QA (en) 2014-08-28
EP2443449A4 (en) 2012-12-26
EA201270020A1 (ru) 2012-07-30
US8914240B2 (en) 2014-12-16
CN102803951A (zh) 2012-11-28
KR20120046171A (ko) 2012-05-09
AU2010260152A1 (en) 2012-02-02
EP2443449A1 (en) 2012-04-25
IL216875A0 (en) 2012-02-29
EP2443449B1 (en) 2017-04-12
US20110015865A1 (en) 2011-01-20
DK2443449T3 (en) 2017-05-15
US9122777B2 (en) 2015-09-01
US20140156198A1 (en) 2014-06-05
JP2012529914A (ja) 2012-11-29

Similar Documents

Publication Publication Date Title
Sager et al. Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
Ahmad et al. Software architectures for robotic systems: A systematic mapping study
BR112012026396A2 (pt) método de gerenciar um programa de premiação a motorista e um sistema para o mesmo
Yao et al. On the properties of small sample of GM (1, 1) model
BR112018073172A2 (pt) método para a identificação de um tipo de erva daninha, sistema de identificação e produto de programa de computador
BR112013018139A2 (pt) método para processar dados genômicos de um indivíduo, uso de informação de sequência genômica, opcionalmente na combinação com informação de expressão de gene, apoio à decisão clínica e sistema de armazenamento e sistema
BR112014001238A2 (pt) método para a detecção de células cancerosas e/ou classificação de células numa amostra de células de líquido; sistema para a detecção de células e/ou a classificação de células cancerosas numa amostra de células; método de atualização e/ou melhoria de uma base de dados que compreende os limiares ligados á informação holográfica; e base de dados de objetos
BR112022004094A2 (pt) Biomarcadores para predizer atividade de doença de esclerose múltipla
BR112016013158A2 (pt) Identificação de candidatos para testes clínicos
BR112012025681A2 (pt) sistema e método para personalizar operações em tempo real em uma interface
EP2827209A3 (en) System and method for assessing cumulative effects of a failure in an aircraft
BRPI0821228A2 (pt) Sistema de modelagem clínica, método para avaliar cenários clínicos hipotéticos, e, processador ou meio legível por computador
AR107503A2 (es) Método para predecir la presencia de al menos un rasgo de búsqueda en una planta, método para seleccionar al menos una planta y método para la extracción de un conjunto de datos relacionados
BRPI0909261A2 (pt) Sistema, produto do programa e métodos relacionados para registro de modelos tridimensionais aos dados de ponto que representam posição de uma roça.
EP2378502A3 (en) Human reliability assessment tool supporting safety issue analysis and management
BR112017003261A2 (pt) método implementado por computador para estimar um movimento, produto de programa armazenado em um meio legível por computador, e, sistema para estimar um movimento.
BR112015006948A2 (pt) sistema para registrar um sistema de coordenadas de um sistema de detecção de formato, método para registrar um sistema de coordenadas de um sistema de detecção de formato e produto de programa de computador
BR112014027578A2 (pt) método em um sistema de processamento de dados para gerar uma linha de base de uso de energia, sistema de processamento de dados configurado para gerar uma linha de base de uso de energia e meio legível por computador não transitório
BR112014028332B8 (pt) Método para fornecer instruções curva-a-curva melhoradas por um dispositivo de navegação pessoal, dispositivo de navegação pessoal e memória legível por computador
FR2926375B1 (fr) Procede d'execution d'une application informatique, kit et aeronef associes
BR112013018261A2 (pt) método para determinação de pelo menos um caminho adequado para o movimento de humano ou tecido animal por meio de um conjunto de dados de intensidade, mídia de leitura por computador, produto de programa de computador e sistema computadorizado
BR112014028103A2 (pt) sistema e método para classificação de fácies
ATE433124T1 (de) System und verfahren zum analysieren von radarinformationen
BR112015005768A2 (pt) aparelho de análise da atividade uterina; método para renderizar o conteúdo relacionado à atividade uterina de um paciente; e programa de computador armazenado em um meio de memória não transitória legível por computador

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DAS PRIORIDADES US 61/187,203 DE 15.06.2009 E US 61/245,190 DE 23.09.2009 POIS NAO FOI RESPONDIDA A EXIGENCIA FORMULADA A NA RPI 2518 DE 09/04/2019 SOBRE ESTAS PRIORIDADES REIVINDICADAS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2534 DE 30-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]